The combination of diabetes and hypertension can silently affect overall health, making it important to know the signs.

NAION risk is most significant within the first 12 months of beginning semaglutide, and is highest in patients with additional risk factors.

Understanding how and why this happens is important not just for those with diabetes, but also for those at risk.

Experts refer to diabetes as a “silent killer”—an ominous label, for sure, but definitely not an exaggeration. Caused by chronic high blood sugar due to the inability of the body to use or produce ...

Amanda Bynes is using Ozempic to lose weight. She wants to weigh 130 lbs. Ozempic is for diabetes but helps with weight loss.

Fact checked by Jennifer Klump GLP-1 drugs may increase the risk of a severe form of macular degeneration in older adults with diabetes, according to a recent study published in JAMA Ophthalmology. A ...

Ozempic and Wegovy, used for diabetes and weight loss, are now linked to a rare eye condition called NAION, or \"eye stroke.\" The European Medicines Ag ...

June 6 (Reuters) - Novo Nordisk's (NOVOb.CO) popular weight-loss and diabetes drugs Wegovy and Ozempic may in very rare cases ...

Called non-arteritic anterior ischemic optic neuropathy (NAION), the condition may affect up to 1 in 10,000 people taking ...

Diabetic neuropathy is caused by cardiovascular changes, genetics, and other risk factors. Diabetes causes vascular changes in small blood vessels throughout the body. This causes a decrease in blood ...